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ENDOTHELIUM-SELECTIVE ACTIVATION OF AMP-ACTIVATED PROTEIN 
KINASE IMPROVES RE-ENDOTHELIALIZATION AND VASCULAR 
FUNCTION VIA INDUCTION OF HEME OXYGENASE-1 IN DIABETIC MICE 
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Medicine and Pharmacology and Pharmacy, University of Hong Kong, China 
 
Reduced number and impaired function of endothelial progenitor cells (EPCs) exacerbate 
vascular injury in diabetes. As AMP-activated kinase (AMPK) is a target of several anti-diabetic 
and cardiovascular drugs, this study investigated whether endothelium-selective activation of 
AMPK prevents diabetes-induced impairment in endothelial repair and vasoreactivity by 
improving EPC functions. Transgenic mice with endothelium-selective expression of a 
constitutively-active (CA-) AMPK were generated and rendered diabetic with streptozotocin. 
Relaxation and re-endothelialization of carotid arteries and circulating EPC numbers were 
examined after wire-induced denudation. Bone marrow-derived EPCs were isolated to monitor 
their in vivo and in vitro functions. In comparison to wild type (WT) littermates, the CA-AMPK 
transgenic mice were resistant to diabetes-induced impairment in re-endothelialization and 
endothelium-dependent relaxation in injured carotid arteries. These changes in the transgenic 
mice were accompanied by increased mobilization of EPCs and enhanced incorporation of EPCs 
into injured vessel walls. Furthermore, EPCs from the transgenic mice exhibited augmented 
adhesion, migration and tubule formation capacities. At the molecular level, the expression of 
heme oxygenase (HO)-1 and secretion of stromal cell-derived factor (SDF)-1α were up-regulated 
in EPCs derived from the transgenic mice, whereas AMPK-mediated elevations of serum SDF-1α 
levels and circulating EPC numbers were abrogated by pharmacological inhibition of HO-1 in 
mice. Thus, endothelium-specific AMPK activation is sufficient to protect against diabetes-
induced vascular injury by promoting EPC functions and re-endothelialization via up-regulation 
of HO-1 and SDF-1α.  
